Tagged with S

Ukraine Rajeev Gupta, co-founder and MD of Kusum Group, the largest Indian company in Ukraine, providing domestically produced generic treatments to the Ukrainian market, describes the challenges of the procurement process and the difficulties of creating brand recognition and respect as an Indian company. Please begin by introducing Kusum Group and…

Colombia Jaime Calderon, CEO of IETS and with an extensive clinical background and deep understanding of the Colombian healthcare sector, shares IETS’ role in advancing the healthcare landscape while promoting superior standards and taking into account the concerns of the population and industry stakeholders. You were appointed CEO of IETS in…

Indonesia Prof. Dr. dr. Fachmi Idris, M.Kes, president director at BPJS Kesehatan explains the evolution of the Universal Healthcare coverage program of Indonesia (JKN-KIS), the challenges inherent in its implementation, and the Indonesian government’s commitment to overcoming them. Dr. Fachmi, can you briefly introduce the main activities and responsibilities of BPJS…

Colombia Pfizer’s country manager and PEH Lead for Colombia & Venezuela, Diego Forero, shares his insights on the Colombian pharmaceutical market, his goals for Pfizer’s Colombian affiliate, and how Colombian operations fit into the group’s worldwide strategy. You just returned after eight years in the USA to lead Pfizer’s Colombian affiliate.…

Indonesia Christian Eberle, president director at APL, explains the challenges and opportunities within the Indonesian healthcare distribution arena as well as the company’s strategy to bring more high-quality medicines to patients over the next two years. After over two years as CEO of APL, could you provide us with an overview…

Switzerland Paul Note, CEO of leading Swiss tissue and bone regeneration specialist Geistlich, discusses how the medtech industry can safeguard success against a challenging economic backdrop, the company’s total commitment to innovation, and its internationalization strategy. Could you please introduce Geistlich to our audience? “We are fortunate to bank upon a…

Colombia Mariella Soto, QuintilesIMS’ country manager for Colombia, has been working in the pharmaceutical-related industry for over 25 years. She explains how her previous experience as a pharmaceutical executive is helping her to develop customer-focused services with QuintilesIMS and the company’s latest innovations in data mining and analysis. You have a…

Indonesia Djonny Hartono Tjahyadi, president director at Enseval, explains the challenges and opportunities within the Indonesian healthcare logistics and distribution arena and his vision to ensure that the company obtains a sustainable double-digit growth level. Can you briefly introduce Enseval’s main activities and responsibilities? “Enseval is the largest distributor in Indonesia…

Ukraine Tetyana Dumenko, director of the State Expert Center (SEC) of the Ministry of Health of Ukraine, the regulatory agency responsible for product registration, pre-clinical studies and clinical trials approval and pharmacovigilance, provides insights into some of her initial achievements since taking the position and her main strategic priorities to further…

Colombia Latin American Regional Head of MSN Labs, one of the most promising generics companies globally, Raman Wattamwar, speaks about the strength of the newly-formed affiliate in Colombia. He highlights Colombia’s optimal potential as a regional hub, the positive business environment for foreign generics players, as well as his overarching strategic…

Hong Kong The Hon. Fanny Law Fan Chiu-fun, chairperson, and Prof. Daniel Lee, head of the Biomedical Technology Cluster, at Hong Kong Science and Technology Parks Corporation (HKSTP) discuss Hong Kong’s potential as an innovation hub, as well as the role that life sciences has to play within this. They also touch…

Colombia Cristhian Salamanca, executive director of the Colombia-India Chamber of Commerce and Industry discusses the ties between both countries, the important role of the chamber in attracting Indian companies to Colombia, and the ease of doing business for pharmaceutical companies in the country after obtaining INVIMA approval. Could you please provide…